BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10071733)

  • 1. Amyopathic dermatomyositis associated with transitional cell carcinoma of the bladder.
    Russ BW; English JC; King DH; Halbach DP
    Cutis; 1999 Feb; 63(2):73-6. PubMed ID: 10071733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review.
    Bientinesi R; Ragonese M; Pinto F; Bassi PF; Sacco E
    Clin Genitourin Cancer; 2016 Apr; 14(2):e199-201. PubMed ID: 26707952
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dermatomyositis as paraneoplastic syndrome of bladder tumor].
    Marchal Escalona C; Vera Casano A; Chicharro Molero JA; Del Rosal Samaniego JM; Ruiz Domínguez JL; Santos García Vaquero A; Burgos Rodríguez R
    Actas Urol Esp; 1992 Jul; 16(7):576-8. PubMed ID: 1442231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare paraneoplastic dermatomyositis in bladder cancer with fatal outcome.
    Xu R; Zhong Z; Jiang H; Zhang L; Zhao X
    Urol J; 2013; 10(1):815-7. PubMed ID: 23504689
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal bladder cancer and dermatomyositis.
    Federman DG; Radonich M; Kirsner RS
    South Med J; 2000 May; 93(5):492-3. PubMed ID: 10832947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatomyositis in association with transitional cell carcinoma of the bladder.
    Mallon E; Osborne G; Dinneen M; Lane RJ; Glaser M; Bunker CB
    Clin Exp Dermatol; 1999 Mar; 24(2):94-6. PubMed ID: 10233662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatomyositis with the features of inclusion body myositis associated with carcinoma of the bladder.
    Talanin NY; Bushore D; Rasberry R; Rudolph T; Tuli M; Friedman-Musicante R
    Br J Dermatol; 1999 Nov; 141(5):926-30. PubMed ID: 10583182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stauffer syndrome in transitional cell carcinoma of the bladder.
    Moreno-Palacios J; Wingartz-Plata H; Pardo-Belasteguigoitia P; Moreno-Aranda J
    Arch Esp Urol; 2011 Nov; 64(9):911-3. PubMed ID: 22155881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmar fasciitis and polyarthritis syndrome associated with transitional cell carcinoma of the bladder.
    Clarke LL; Kennedy CT; Hollingworth P
    J Am Acad Dermatol; 2011 Jun; 64(6):1159-63. PubMed ID: 20638154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatomyositis in association with transitional cell carcinoma of the bladder.
    Robinson AJ; Alcock CJ
    Clin Oncol (R Coll Radiol); 2001; 13(1):50-1. PubMed ID: 11292137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic leukemoid reaction as marker for transitional cell carcinoma recurrence.
    Dukes JW; Tierney LM
    Urology; 2009 Apr; 73(4):928.e17-9. PubMed ID: 18718647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukemoid reaction and hypercalcemia in carcinoma of the bladder].
    Alamé T; De Weweire A; Gris P; Coffernils M; Van den Heule B; Delmez JP; Longeval E
    Rev Med Brux; 1990 Mar; 11(3):59-62. PubMed ID: 2181581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly progressive transitional cell carcinoma associated with dermatomyositis.
    Rankin WR; Herman JR
    J Urol; 2002 Feb; 167(2 Pt 1):639-40. PubMed ID: 11792936
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermatomyositis without muscle weakness associated with transitional cell carcinoma of the bladder.
    Apaydin R; Gül U; Bahadir S; Siviloglu C; Ofluoglu I
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):172-4. PubMed ID: 12046828
    [No Abstract]   [Full Text] [Related]  

  • 15. High-grade transitional cell carcinoma and melanosis of urinary bladder: case report and review of the literature.
    Sanborn SL; MacLennan G; Cooney MM; Zhou M; Ponsky LE
    Urology; 2009 Apr; 73(4):928.e13-5. PubMed ID: 19056107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leser-Trélat sign associated with Sézary syndrome and transitional cell carcinoma of the bladder].
    Martínez-Morán C; Sanz-Muñoz C; Miranda-Romero A
    Actas Dermosifiliogr; 2007 Apr; 98(3):214-5. PubMed ID: 17504710
    [No Abstract]   [Full Text] [Related]  

  • 17. Dysphagia in dermatomyositis secondary to bladder cancer: rapid response to combined immunoglobulin and methylprednisolone.
    Hafejee A; Coulson IH
    Clin Exp Dermatol; 2005 Jan; 30(1):93-4. PubMed ID: 15663519
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuromyotonia as paraneoplastic manifestation of bladder carcinoma.
    Forte F; Pretegiani E; Battisti C; Sicurelli F; Federico A
    J Neurol Sci; 2009 May; 280(1-2):111-2. PubMed ID: 19249799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous sarcoid reaction in a patient with bladder cancer.
    Yukawa M; Satoh T; Takayama K; Yokozeki H
    Eur J Dermatol; 2010; 20(2):235. PubMed ID: 20007063
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leukemoid reaction as a paraneoplastic manifestation of bladder carcinoma].
    Caballero Alcántara JE; Castro Pita MA; Carrero López V; Rodríguez Antolin A; Pamplona Casamayor M; Leiva Galvis O
    Actas Urol Esp; 1991; 15(5):496-9. PubMed ID: 1807134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.